| John S Schell, PHD | |
|
4833 Darrow Road Suite 101, Stow, OH 44224-1411 | |
| (330) 650-5338 | |
| (330) 342-3837 |
| Full Name | John S Schell |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 26 Years |
| Location | 4833 Darrow Road Suite 101, Stow, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518927748 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Western Reserve Psychological Assoc Inc | 4587644489 | 8 |
News Archive
NephRx Corporation today announced that a new study has shown that its novel peptide NX002 demonstrated significant efficacy when tested in an animal model of oral mucositis. Mucositis is a debilitating and often dose-limiting side effect of many forms of cancer therapy that affects more than 400,000 patients who receive chemotherapy or radiation treatment in the U.S. each year. Current treatment options are very limited.
Carolinas MED-1 - the first mobile hospital of its kind in the world - will be serving the people of Charlotte and Mecklenburg County when it is deployed this Saturday for an H1N1 vaccine clinic.
An analysis of trends in sudden unexpected infant death (SUID) over the past two decades finds that the drop in such deaths that took place following release of the 1992 American Academy of Pediatrics (AAP) "back to sleep" recommendations, did not occur in infants in the first month of life.
The FDA has released the following statement on NIH halting a clinical trial involving non-steroidal anti-inflammatory drugs in patients at risk of developing Alzheimer's Disease:
› Verified 9 days ago
| Entity Name | Western Reserve Psychological Assoc Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063479590 PECOS PAC ID: 4587644489 Enrollment ID: O20040721001612 |
News Archive
NephRx Corporation today announced that a new study has shown that its novel peptide NX002 demonstrated significant efficacy when tested in an animal model of oral mucositis. Mucositis is a debilitating and often dose-limiting side effect of many forms of cancer therapy that affects more than 400,000 patients who receive chemotherapy or radiation treatment in the U.S. each year. Current treatment options are very limited.
Carolinas MED-1 - the first mobile hospital of its kind in the world - will be serving the people of Charlotte and Mecklenburg County when it is deployed this Saturday for an H1N1 vaccine clinic.
An analysis of trends in sudden unexpected infant death (SUID) over the past two decades finds that the drop in such deaths that took place following release of the 1992 American Academy of Pediatrics (AAP) "back to sleep" recommendations, did not occur in infants in the first month of life.
The FDA has released the following statement on NIH halting a clinical trial involving non-steroidal anti-inflammatory drugs in patients at risk of developing Alzheimer's Disease:
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John S Schell, PHD 4833 Darrow Road Suite 101, Stow, OH 44224-1411 Ph: (330) 650-5338 | John S Schell, PHD 4833 Darrow Road Suite 101, Stow, OH 44224-1411 Ph: (330) 650-5338 |
News Archive
NephRx Corporation today announced that a new study has shown that its novel peptide NX002 demonstrated significant efficacy when tested in an animal model of oral mucositis. Mucositis is a debilitating and often dose-limiting side effect of many forms of cancer therapy that affects more than 400,000 patients who receive chemotherapy or radiation treatment in the U.S. each year. Current treatment options are very limited.
Carolinas MED-1 - the first mobile hospital of its kind in the world - will be serving the people of Charlotte and Mecklenburg County when it is deployed this Saturday for an H1N1 vaccine clinic.
An analysis of trends in sudden unexpected infant death (SUID) over the past two decades finds that the drop in such deaths that took place following release of the 1992 American Academy of Pediatrics (AAP) "back to sleep" recommendations, did not occur in infants in the first month of life.
The FDA has released the following statement on NIH halting a clinical trial involving non-steroidal anti-inflammatory drugs in patients at risk of developing Alzheimer's Disease:
› Verified 9 days ago
Lori Marie Wills, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4833 Darrow Rd Ste 100, Stow, OH 44224 Phone: 330-422-3255 Fax: 330-422-3256 | |
Mary E. Hickcox, Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4833 Darrow Rd, Suite 101, Stow, OH 44224 Phone: 330-650-5338 Fax: 330-342-3837 | |
Richard J Shurell, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4833 Darrow Road Suite 101, Western Reserve Psychological Associates Inc, Stow, OH 44224 Phone: 330-650-5338 Fax: 330-342-3837 | |
Suzanne H Hetrick, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4833 Darrow Road Suite 101, Stow, OH 44224 Phone: 330-650-5338 Fax: 330-342-3837 | |
Dr. Jay Levine, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4833 Darrow Rd, Suite 101, Stow, OH 44224 Phone: 330-650-5338 Fax: 330-342-3837 | |
Carole P Smith, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4833 Darrow Road Suite 101, Stow, OH 44224 Phone: 330-650-5338 Fax: 330-342-3837 | |
Donna Mcdonald, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 4833 Darrow Rd Ste 101, Stow, OH 44224 Phone: 330-650-5338 |